Clinical Trials Browser

OTHER × Myasthenic Syndromes, Congenital × Amifampridine × Clear all

NCT00872950 2022-04-11

LEMS

Approved for marketing

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

NCT02012933 2019-12-11

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

No longer available

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital